Affiliation:
1. Department of Cardiology, West China Hospital, Sichuan University, Chengdu, China
2. Cedars–Sinai Heart Institute, Cedars–Sinai Medical Center, Los Angeles, CA
Abstract
Background
Transcatheter aortic valve replacement (
TAVR
) is an effective alternative to surgical aortic valve replacement in patients at high surgical risk. However, there is little published literature on the exact causes of death.
Methods and Results
The PubMed database was systematically searched for studies reporting causes of death within and after 30 days following
TAVR
. Twenty‐eight studies out of 3934 results retrieved were identified. In the overall analysis, 46.4% and 51.6% of deaths were related to noncardiovascular causes within and after the first 30 days, respectively. Within 30 days of
TAVR
, infection/sepsis (18.5%), heart failure (14.7%), and multiorgan failure (13.2%) were the top 3 causes of death. Beyond 30 days, infection/sepsis (14.3%), heart failure (14.1%), and sudden death (10.8%) were the most common causes. All possible subgroup analyses were made. No significant differences were seen for proportions of cardiovascular deaths except the comparison between moderate (mean
STS
score 4 to 8) and high (mean
STS
score >8) ‐risk patients after 30 days post‐
TAVR
(56.0% versus 33.5%,
P
=0.005).
Conclusions
Cardiovascular and noncardiovascular causes of death are evenly balanced both in the perioperative period and at long‐term follow‐up after
TAVR
. Infection/sepsis and heart failure were the most frequent noncardiovascular and cardiovascular causes of death. This study highlights important areas of clinical focus that could further improve outcomes after
TAVR
.
Publisher
Ovid Technologies (Wolters Kluwer Health)
Subject
Cardiology and Cardiovascular Medicine
Cited by
53 articles.
订阅此论文施引文献
订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献